Ken Fisher
ANIP icon

Ken Fisher’s ANI Pharmaceuticals ANIP Stock Holding History

Ken Fisher’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56
Closed -$3.25K – 985
2023
Q3 		$3.25K Hold
56
– – ﹤0.01% 1128
2023
Q2 		$3.01K Hold
56
– – ﹤0.01% 1128
2023
Q1 		$2.22K Buy
+56
New +$2.36K ﹤0.01% 1100

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ken Fisher's ANIP Position: Q4 2023 in Review

Ken Fisher sold out of ANI Pharmaceuticals (ANIP) in Q4 2023, closing a stake of 56 shares — an estimated $3.25K sold.

Ken Fisher first reported a position in ANIP in Q1 2023 and held it in 3 quarters. The position peaked at $3.25K in Q3 2023. 182 funds tracked by Wall St. Rank hold ANIP as of Q4 2023.

  • Ken Fisher reported no remaining ANI Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Ken Fisher sold 56 ANI Pharmaceuticals shares in Q4 2023, an estimated $3.25K.
  • Ken Fisher first reported a position in ANI Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Ken Fisher's ANI Pharmaceuticals position peaked at $3.25K in Q3 2023.
  • 182 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.